Expectations trend
FY2027 · fiscal year ending 2027-12-27 · fmp
CPS Technologies Corp (CPSH)
NASDAQInformation TechnologyHardware, Equipment & PartsSnapshot 2026-11-04
$3.60-6.49%
Close 2026-11-05 · 1-day change
NASDAQInformation TechnologyHardware, Equipment & PartsSnapshot 2026-11-04
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
0.06 → 0.06 EPS · FY ending Dec 27, 2027 · 1 analyst
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
Change in the same fiscal period’s mean EPS estimate from Oct 5, 2026 to Nov 4, 2026: (new ÷ prior − 1). Contributor count changed from 1 to 1; this is not the number of analysts revising. The ±10% axis is a display range.
The EPS and P/E reference is not available for CPSH yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
Three published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Successful CFO transition to Christopher S. Fraser | A supporting condition in CPS Technologies Corp's published investment case. The stated target is CFO transition completed and stabilizing by mid-2026. | Intact | CFO transition fails or causes disruption beyond 2026-Q2 | CFO transition completed May 2026 vs mid-2026 target New CFO Christopher S. Fraser hired in May 2026 to replace retiring Charles K. Griffith Jr. Nov 4, 2026Last status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
FY2027 · fiscal year ending 2027-12-27 · fmp
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Next earnings date unavailable
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Review earningsObserved price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
CPSH is a high-risk, loss-making business with an improvement-driven multi-year view, rather than a proven durable compounder. Its thesis is in a watch state: recent results show progress, but performance remains below its industry cohort and confidence has eased to medium.
The valuation evidence points in different directions: CPSH is described as cheap versus peers, while the valuation model also shows a premium versus peers. The model has low confidence, and the expectations gap is negative, so the market setup is not clearly supportive or demanding based on this evidence alone. The priced-in tag is justified, with low fragility.
Near term, management's stated focus on revenue growth and gross-margin expansion is showing progress: revenue rose from $7.0 million in Q1 2026 to $8.3 million in Q2, and gross margin improved from 8.6% to 14.8%, though it remains below prior-year levels. Management also reports planning and site negotiations for a larger facility, but the evidence does not quantify its financial effect. The business remains loss-making and high-risk, and a guidance cut on the next call is a stated downside trigger.
Over the next few quarters, the thesis hinges on continued revenue growth, further margin progress, and execution on the facility move. A guidance cut would be a meaningful negative; rate cuts or stabilization among sector bellwethers are identified as possible tailwinds, but neither is assured.
For the 1-to-3-year view, CPSH has early operating progress but no established path past losses, and its below-cohort performance keeps the thesis conditional. The main evidence to watch is whether revenue and margins keep improving without a guidance setback. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
| The company targets gross margins near 16.5% in 2025. |
| Broken |
| Gross margin falls below 15% in FY25 |
Gross margin: 14.79% FY2026-Q2; GAAP. Published target: >= 16.5%. Annual target cannot be compared with a quarterly or TTM observation. Aug 11, 202614.788076 percent · calculatedLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Revenue at or above $32.6M by FY26 | A primary condition in CPS Technologies Corp's published investment case. The stated target is >= $32.6M. | Intact | Revenue falls below $30M in FY26 | Revenue: $8.309M FY2026-Q2; GAAP. Published target: >= $32.6M. Annual target cannot be compared with a quarterly or TTM observation. Aug 11, 20268,309,323 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextStated in 1 of 1 supplied quarters. Management reported: “Results of Operations CPS reported revenue of $8.3 million for the second quarter of fiscal 2026 versus $8.1 million in the prior-year period.” “Results of Operations CPS reported revenue of $7.0 million for the first quarter of fiscal 2026 versus $7.5 million in the prior-year period, primarily reflecting order timing.” Revenue was $8.309 million in 2026-Q2. Delivery assessment Nov 4, 2026 |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
$0.18 → $0.06 · observed estimates
$0.04B → $0.03B · observed estimates
One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.
| Snapshot | EPS | Revenue | EPS / revenue analysts |
|---|---|---|---|
| 2026-07-24 | $0.18 | $42,280,000 | 1 / 1 |
| 2026-07-25 | $0.18 | $42,280,000 | 1 / 1 |
| 2026-07-26 | $0.18 | $42,280,000 | 1 / 1 |
| 2026-07-27 | $0.18 | $42,280,000 | 1 / 1 |
| 2026-07-28 | $0.18 | $42,280,000 | 1 / 1 |
| 2026-07-29 | $0.18 | $42,280,000 | 1 / 1 |
| 2026-07-30 | $0.18 | $42,280,000 | 1 / 1 |
| 2026-07-31 | $0.18 | $42,280,000 | 1 / 1 |
| 2026-08-01 | $0.18 | $42,280,000 | 1 / 1 |
| 2026-08-02 | $0.18 | $42,280,000 | 1 / 1 |
| 2026-08-03 | $0.18 | $42,280,000 | 1 / 1 |
| 2026-08-04 | $0.18 | $42,280,000 | 1 / 1 |
| 2026-08-05 | $0.18 | $42,280,000 | 1 / 1 |
| 2026-08-06 | $0.18 | $42,280,000 | 1 / 1 |
| 2026-08-07 | $0.18 | $42,280,000 | 1 / 1 |
| 2026-08-08 | $0.18 | $42,280,000 | 1 / 1 |
| 2026-08-09 | $0.18 | $42,280,000 | 1 / 1 |
| 2026-08-10 | $0.18 | $42,280,000 | 1 / 1 |
| 2026-08-11 | $0.18 | $42,280,000 | 1 / 1 |
| 2026-08-12 | $0.18 | $42,280,000 | 1 / 1 |
| 2026-08-13 | $0.18 | $42,280,000 | 1 / 1 |
| 2026-08-14 | $0.18 | $42,280,000 | 1 / 1 |
| 2026-08-15 | $0.18 | $42,280,000 | 1 / 1 |
| 2026-08-16 | $0.18 | $42,280,000 | 1 / 1 |
| 2026-08-17 | $0.18 | $42,280,000 | 1 / 1 |
| 2026-08-18 | $0.18 | $42,280,000 | 1 / 1 |
| 2026-08-19 | $0.18 | $42,280,000 | 1 / 1 |
| 2026-08-20 | $0.06 | $34,670,000 | 1 / 1 |
| 2026-08-21 | $0.06 | $34,670,000 | 1 / 1 |
| 2026-08-22 | $0.06 | $34,670,000 | 1 / 1 |
| 2026-08-23 | $0.06 | $34,670,000 | 1 / 1 |
| 2026-08-24 | $0.06 | $34,670,000 | 1 / 1 |
| 2026-08-25 | $0.06 | $34,670,000 | 1 / 1 |
| 2026-08-26 | $0.06 | $34,670,000 | 1 / 1 |
| 2026-08-27 | $0.06 | $34,670,000 | 1 / 1 |
| 2026-08-28 | $0.06 | $34,670,000 | 1 / 1 |
| 2026-08-29 | $0.06 | $34,670,000 | 1 / 1 |
| 2026-08-30 | $0.06 | $34,670,000 | 1 / 1 |
| 2026-08-31 | $0.06 | $34,670,000 | 1 / 1 |
| 2026-09-01 | $0.06 | $34,670,000 | 1 / 1 |
| 2026-09-02 | $0.06 | $34,670,000 | 1 / 1 |
| 2026-09-03 | $0.06 | $34,670,000 | 1 / 1 |
| 2026-09-04 | $0.06 | $34,670,000 | 1 / 1 |
| 2026-09-05 | $0.06 | $34,670,000 | 1 / 1 |
| 2026-09-06 | $0.06 | $34,670,000 | 1 / 1 |
| 2026-09-07 | $0.06 | $34,670,000 | 1 / 1 |
| 2026-09-08 | $0.06 | $34,670,000 | 1 / 1 |
| 2026-09-09 | $0.06 | $34,670,000 | 1 / 1 |
| 2026-09-10 | $0.06 | $34,670,000 | 1 / 1 |
| 2026-09-11 | $0.06 | $34,670,000 | 1 / 1 |
| 2026-09-12 | $0.06 | $34,670,000 | 1 / 1 |
| 2026-09-13 | $0.06 | $34,670,000 | 1 / 1 |
| 2026-09-14 | $0.06 | $34,670,000 | 1 / 1 |
| 2026-09-15 | $0.06 | $34,670,000 | 1 / 1 |
| 2026-09-16 | $0.06 | $34,670,000 | 1 / 1 |
| 2026-09-17 | $0.06 | $34,670,000 | 1 / 1 |
| 2026-09-18 | $0.06 | $34,670,000 | 1 / 1 |
| 2026-09-19 | $0.06 | $34,670,000 | 1 / 1 |
| 2026-09-20 | $0.06 | $34,670,000 | 1 / 1 |
| 2026-09-21 | $0.06 | $34,670,000 | 1 / 1 |
| 2026-09-22 | $0.06 | $34,670,000 | 1 / 1 |
| 2026-09-23 | $0.06 | $34,670,000 | 1 / 1 |
| 2026-09-24 | $0.06 | $34,670,000 | 1 / 1 |
| 2026-09-25 | $0.06 | $34,670,000 | 1 / 1 |
| 2026-09-26 | $0.06 | $34,670,000 | 1 / 1 |
| 2026-09-27 | $0.06 | $34,670,000 | 1 / 1 |
| 2026-09-28 | $0.06 | $34,670,000 | 1 / 1 |
| 2026-09-29 | $0.06 | $34,670,000 | 1 / 1 |
| 2026-09-30 | $0.06 | $34,670,000 | 1 / 1 |
| 2026-10-01 | $0.06 | $34,670,000 | 1 / 1 |
| 2026-10-02 | $0.06 | $34,670,000 | 1 / 1 |
| 2026-10-03 | $0.06 | $34,670,000 | 1 / 1 |
| 2026-10-04 | $0.06 | $34,670,000 | 1 / 1 |
| 2026-10-05 | $0.06 | $34,670,000 | 1 / 1 |
| 2026-10-06 | $0.06 | $34,670,000 | 1 / 1 |
| 2026-10-07 | $0.06 | $34,670,000 | 1 / 1 |
| 2026-10-08 | $0.06 | $34,670,000 | 1 / 1 |
| 2026-10-09 | $0.06 | $34,670,000 | 1 / 1 |
| 2026-10-10 | $0.06 | $34,670,000 | 1 / 1 |
| 2026-10-11 | $0.06 | $34,670,000 | 1 / 1 |
| 2026-10-12 | $0.06 | $34,670,000 | 1 / 1 |
| 2026-10-13 | $0.06 | $34,670,000 | 1 / 1 |
| 2026-10-14 | $0.06 | $34,670,000 | 1 / 1 |
| 2026-10-15 | $0.06 | $34,670,000 | 1 / 1 |
| 2026-10-16 | $0.06 | $34,670,000 | 1 / 1 |
| 2026-10-17 | $0.06 | $34,670,000 | 1 / 1 |
| 2026-10-18 | $0.06 | $34,670,000 | 1 / 1 |
| 2026-10-19 | $0.06 | $34,670,000 | 1 / 1 |
| 2026-10-20 | $0.06 | $34,670,000 | 1 / 1 |
| 2026-10-21 | $0.06 | $34,670,000 | 1 / 1 |
| 2026-10-22 | $0.06 | $34,670,000 | 1 / 1 |
| 2026-10-23 | $0.06 | $34,670,000 | 1 / 1 |
| 2026-10-24 | $0.06 | $34,670,000 | 1 / 1 |
| 2026-10-25 | $0.06 | $34,670,000 | 1 / 1 |
| 2026-10-26 | $0.06 | $34,670,000 | 1 / 1 |
| 2026-10-27 | $0.06 | $34,670,000 | 1 / 1 |
| 2026-10-28 | $0.06 | $34,670,000 | 1 / 1 |
| 2026-10-29 | $0.06 | $34,670,000 | 1 / 1 |
| 2026-10-30 | $0.06 | $34,670,000 | 1 / 1 |
| 2026-10-31 | $0.06 | $34,670,000 | 1 / 1 |
| 2026-11-01 | $0.06 | $34,670,000 | 1 / 1 |
| 2026-11-02 | $0.06 | $34,670,000 | 1 / 1 |
| 2026-11-03 | $0.06 | $34,670,000 | 1 / 1 |
| 2026-11-04 | $0.06 | $34,670,000 | 1 / 1 |
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Latest: 1 Buy / Strong Buy · 0 Hold · 0 Sell / Strong Sell
Recent actions · Oct 6–Nov 4 · 0 recorded
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Oct 6, 2026–Nov 4, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
2 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.